Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bourgeois

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Vaccine|January 1, 1995
Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primatesS Baqar, A L Bourgeois, P J Schultheiss, et al.
The Journal of Biological Chemistry|December 31, 1997
Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2L Bourgeois, M Brillard-Bourdet, D Deperthes, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1994
Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in EgyptS Bassily, K C Hyams, N A el-Masry, et al.
Infection and Immunity|October 26, 1999
Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuniL H Lee, E Burg, S Baqar, et al.
Vaccine|April 2, 2013
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvantJ Holmgren, L Bourgeois, N Carlin, et al.
Vaccine|January 12, 2013
Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid proteinA Lundgren, S Leach, J Tobias, et al.
Journal of Diarrhoeal Diseases Research|March 1, 1993
Campylobacter-associated diarrhoea in Egyptian infants: epidemiology and clinical manifestations of disease and high frequency of concomitant infectionsG Pazzaglia, A L Bourgeois, I Araby, et al.
Journal of Affective Disorders|January 1, 2003
Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II)Hagop S Akiskal, Elie-Georges Hantouche, Jean-François Allilaire, et al.
Infection and Immunity|November 18, 2000
Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cellsT E Hickey, A L McVeigh, D A Scott, et al.
Journal of Affective Disorders|March 1, 2002
The feasibility of self-assessment of dysphoric mania in the French national EPIMAN studyE G Hantouche, J P Allilaire, M L Bourgeois, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Vaccine|January 1, 1995
Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primatesS Baqar, A L Bourgeois, P J Schultheiss, et al.
The Journal of Biological Chemistry|December 31, 1997
Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2L Bourgeois, M Brillard-Bourdet, D Deperthes, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1994
Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in EgyptS Bassily, K C Hyams, N A el-Masry, et al.
Infection and Immunity|October 26, 1999
Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuniL H Lee, E Burg, S Baqar, et al.
Vaccine|April 2, 2013
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvantJ Holmgren, L Bourgeois, N Carlin, et al.
Vaccine|January 12, 2013
Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid proteinA Lundgren, S Leach, J Tobias, et al.
Journal of Diarrhoeal Diseases Research|March 1, 1993
Campylobacter-associated diarrhoea in Egyptian infants: epidemiology and clinical manifestations of disease and high frequency of concomitant infectionsG Pazzaglia, A L Bourgeois, I Araby, et al.
Journal of Affective Disorders|January 1, 2003
Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II)Hagop S Akiskal, Elie-Georges Hantouche, Jean-François Allilaire, et al.
Infection and Immunity|November 18, 2000
Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cellsT E Hickey, A L McVeigh, D A Scott, et al.
Journal of Affective Disorders|March 1, 2002
The feasibility of self-assessment of dysphoric mania in the French national EPIMAN studyE G Hantouche, J P Allilaire, M L Bourgeois, et al.
Pageof 16